What sector does Concord Biotech Limited belong to?
Concord Biotech Limited operates in the Healthcare sector, specifically the Pharmaceuticals industry, and is listed on the NSE.
What is the current share price of CONCORDBIO?
As of the latest available quote, CONCORDBIO traded at ₹1,510.00. This price is delayed and cached for about 15 minutes.
What is the P/E ratio of CONCORDBIO?
Concord Biotech Limited has a price-to-earnings (P/E) ratio of about 51.96. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.
What is the market capitalisation of CONCORDBIO?
The market capitalisation of Concord Biotech Limited is approximately ₹15,752 Cr.
Is Concord Biotech Limited profitable?
For its latest reported financial year, Concord Biotech Limited recorded a net profit margin of about 24.55%.
Does CONCORDBIO pay a dividend?
Concord Biotech Limited does not currently show a dividend yield in our data.
What is the return on equity (ROE) of CONCORDBIO?
Concord Biotech Limited has a return on equity (ROE) of about 12.50%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of CONCORDBIO?
Over the past 52 weeks, CONCORDBIO has traded between a low of ₹987.00 and a high of ₹1,704.00.
These answers are generated from reported financial data and live market figures, for educational and informational purposes only.